Photo coming soon
RT-3 (GLP-3)
Shipping and payment
Chemistry & specifications
Reference data from public databases. For research use only.
| CAS Number | 2381089-83-2 |
|---|---|
| Molecular Formula | C221H342N46O68 |
| Molecular Weight | 4731 g/mol |
| Residue Count | 39 |
| Sequence (1-letter) | YXQGTFTSDYSIXLDKKAQXAFIEYLLEGGPSSGAPPPS |
| PubChem CID | 171390338 → |
Common questions
What pack sizes and strengths are available for RT-3 (GLP-3)?
RT-3 (GLP-3) is offered as a 3-vial kit, a single vial, or a 10-vial box. Available strengths: 5 mg, 10 mg, 15 mg, 20 mg, 30 mg, 40 mg, 50 mg, and 60 mg per vial. Every vial in a kit or box is the strength you select. The price per vial for each pack is shown under the price.
How quickly does RT-3 (GLP-3) ship?
RT-3 (GLP-3) in 5 mg, 10 mg, 20 mg, and 30 mg ships the same day when you order Monday to Friday before 3:00 PM Pacific. Orders after the cutoff, on weekends, or on US federal holidays ship the next business day, and never later than 2 business days after the order. The 15 mg, 40 mg, 50 mg, and 60 mg strengths are prepared to order and dispatched within 7 business days. Carrier transit then takes up to 3 business days within the contiguous United States. Standard shipping is a $18.99 flat rate and free on orders over $200.
How should RT-3 (GLP-3) be stored?
Lyophilized (freeze-dried) vials tolerate normal shipping at room temperature. On arrival, keep them sealed, dry and away from light: a refrigerator at about 4 °C for the short term, or −20 °C or colder for long-term storage. Let a cold vial reach room temperature before opening it so moisture does not condense on the powder.
How do I work out the concentration after reconstitution?
Concentration in mg/mL equals the vial amount in mg divided by the mL of solvent added. Our free reconstitution calculator also shows the mg held at each 0.1 mL mark.
Is RT-3 (GLP-3) for human use?
No. RT-3 (GLP-3) is sold strictly for laboratory research use. It is not a drug, food, dietary supplement, or cosmetic, has not been evaluated by the FDA, and is not for human or veterinary use. Purchasers must be 21 or older.
Research background
Chemistry, identity, and a summary of the peer-reviewed literature on RT-3 (GLP-3).
Read the RT-3 (GLP-3) research background → Reconstitution calculator →Peer-reviewed research
Every research claim on this page traces to one of the 4 publications below.
- Triple-Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 TrialN Engl J Med (2023)View publication →
- Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trialNat Med (2024)View publication →
- Effects of retatrutide on body composition in people with type 2 diabetes: a substudy of a phase 2, double-blind, parallel-group, placebo-controlled, randomised trialLancet Diabetes Endocrinol (2025)View publication →
- Efficacy and safety of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with type 2 diabetes and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, phase 3 trialLancet (2026)View publication →



